Reduced Brain Cannabinoid Receptor Availability In Schizophrenia

BACKGROUND: Several lines of evidence suggest the presence of abnormalities in the endocannabinoid (eCB) system in schizophrenia (SCZ). However, there are limited in vivo measures of the eCB system in SCZ. METHODS: Twenty five male SCZ subjects (SCZs), 18 antipsychotic treated [SCZ-MED] and 7 antips...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Psychiatry
Main Authors: Ranganathan, Mohini, Cortes, Jose, Radhakrishnan, Rajiv, Thurnauer, Halle, Planeta, Beata, Skosnik, Patrick, Gao, Hong, Labaree, David, Neumeister, Alexander, Pittman, Brian, Surti, Toral, Huang, Yiyun, Carson, Richard E., D’Souza, Deepak Cyril
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
https://ncbi.nlm.nih.gov/pubmed/26432420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2015.08.021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados